To investigate whether MNX1 can regulate PD‐L1 mRNA stability, we treated MNX1‐KO or overexpressing ESCC cells with actinomycin D, an RNA synthesis inhibitor. The gene discussed is MNX1; the disease is esophageal squamous cell carcinoma.